13.1 Routine Antenatal Care, Gestational Diabetes Screening, and Infectious Disease Screening

Key Takeaways

  • Book early, offer dating and fetal anatomy ultrasound, and reassess risk throughout pregnancy. Coordinate maternity and addiction care early when substance dependence is identified.

  • Apply the Irish pregnancy VTE risk assessment repeatedly through pregnancy and postpartum. Choose prophylaxis by risk and clinical context.

  • Anti-D eligibility and dosing depend on sensitisation status, fetal or newborn RhD, gestation, event and product. Routine antenatal prophylaxis does not replace event-related prophylaxis.

  • Act on positive infection screening through the appropriate specialist pathway. Offer indicated MMR after birth for rubella susceptibility.

  • Arrange specialist preconception or early review for established diabetes. Check ketones urgently if a pregnant patient with diabetes is unwell. For gestational diabetes, use the local thresholds and arrange postpartum OGTT at 6–12 weeks under the Irish model.

Last updated: November 2026

Use the booking visit to assess risk

Arrange antenatal care early. The HSE describes an initial maternity appointment usually at 8–12 weeks. Confirm pregnancy history, previous birth outcomes, medical and surgical history, medicines, family history, and needs for support. Ask privately about smoking, alcohol, prescribed and non-prescribed drugs, mental health and safety at home. Clarify recent use, dependence, previous withdrawal and who is already providing care. Discuss available care pathways and refer for specialist care when the history or findings indicate higher risk.

Alcohol and drug use. The HSE advises avoiding alcohol throughout pregnancy. When dependence or withdrawal is possible, arrange prompt clinical assessment and a medically supervised plan. For a patient stable on prescribed opioid substitution treatment, support continuity and coordinate early with the maternity service and addiction prescriber. A drug liaison midwife can help where available. Abrupt withdrawal or an unsupported switch risks destabilising treatment. Review other drugs and sedatives individually, and plan perinatal follow-up with maternity and neonatal staff because an exposed newborn may need observation and treatment for withdrawal. Discuss safeguarding based on the identified risk to the child and follow the local safeguarding pathway where there is concern.

HSE alcohol advice · HSE pregnancy and drug use · HSE opioid substitution guideline, section 7.5.

Record baseline blood pressure with a suitable cuff, height, weight and BMI. Booking investigations include full blood count, ABO and RhD group, red-cell antibody screen and offered infection screening. Assess urine as indicated. Review nutrition, vaccination, medication safety and eligibility for preventive treatments such as aspirin when indicated.

With obesity, discuss nutrition, activity and appropriate gestational weight gain respectfully and arrange dietetic or multidisciplinary support when needed. Plan support for weight management before a future pregnancy and after birth, when follow-up can include complications such as gestational diabetes. Ask about habitual loud snoring, witnessed apnoeas and known sleep apnoea in an at-risk patient. Discuss assessment and the anaesthetic and postpartum monitoring plan with the maternity team if obstructive sleep apnoea is suspected or known. Follow the Irish preassessment pathway for obstetric anaesthetic referral. HSE obesity model of care · SASM/SOAP sleep apnoea in pregnancy guideline.

  • Asymptomatic bacteriuria. Maternity booking urine-culture screening depends on local policy. A urine dipstick alone cannot screen for bacterial UTI in pregnancy. HSE AMRIC advises confirming asymptomatic bacteriuria with two consecutive cultures, preferably within two weeks. Its exception is group B streptococcus above 100,000 CFU/mL, which should be treated without waiting for a repeat. Treat confirmed bacteriuria with an antibiotic selected for susceptibility and gestation, then confirm clearance by culture. Avoid nitrofurantoin after 36+0 weeks under this guidance. Arrange separate obstetric review of intrapartum GBS prophylaxis where relevant.
  • Supplements. The HSE advises 400 micrograms folic acid daily before and during pregnancy and 15 micrograms vitamin D daily during pregnancy. A higher prescribed folic acid dose is appropriate for selected higher-risk patients, including pre-existing diabetes or a prior neural tube defect. Review dose and duration for the individual's indication. A higher BMI also prompts assessment for diabetes, hypertension, VTE and anaesthetic or birth-planning needs.
  • VTE prevention. Under the Irish guideline effective 21 October 2026, document VTE risk at pregnancy confirmation, hospital booking, every antenatal admission, in the third trimester, immediately after pregnancy and at postpartum admissions up to three months. Repeat when new risk factors or changes in clinical status occur. Prior VTE or high-risk thrombophilia warrants specialist planning. Use the national scoring pathway to identify patients who need low-molecular-weight heparin prophylaxis and review bleeding risk.

HSE maternity appointments · HSE nutrition in pregnancy · HSE AMRIC asymptomatic bacteriuria · Irish pregnancy VTE guideline, 2026

Date pregnancy and monitor growth

The HSE offers a dating scan before 15 weeks. Early ultrasound confirms viability, estimates gestation and identifies multiple pregnancy. Use crown–rump length when appropriate and the maternity ultrasound pathway for later biometry and reconciliation with menstrual dating. The Irish fetal anatomy guideline recommends offering an anatomy scan after 18 and before 22 weeks, ideally at 20–22 weeks. The scan includes fetal anatomy and placental assessment.

The Maternity and Infant Care Scheme provides scheduled visits with the GP and maternity service. The sequence depends on the service, individual risks and findings. Reassess BP, fetal growth, symptoms and the care plan at follow-up. Symphysis–fundal height can be used to screen selected normal-risk pregnancies under the Irish fetal growth pathway. Interpret the serial measurements using the appropriate chart. A concerning trajectory or risk factors such as prior growth restriction can warrant ultrasound rather than relying on a centimetre-to-weeks rule. New reduced fetal movements require prompt maternity assessment.

HSE dating scan · Irish fetal anatomy ultrasound · Irish growth restriction guidance

Investigate significant itching in pregnancy

Ask where the itch started, whether there is a rash, and about onset and other symptoms. Significant itch without a primary rash, often involving palms or soles, can indicate intrahepatic cholestasis of pregnancy. Arrange prompt maternity review with serum bile acids and liver tests. Bile acids can be abnormal despite normal liver tests. If initial tests are normal and symptoms continue without a clear cause, arrange repeat testing. Examine for other causes, including a primary skin disorder.

Confirmed cholestasis needs an individual obstetric plan using bile acid results and other maternal or fetal risks. New reduced fetal movements require immediate contact with the maternity unit. Check that symptoms and blood test abnormalities resolve after birth.

HSE skin symptoms during pregnancy · Irish stillbirth guideline · RCOG Green-top 43 clinical guidance

Distinguish RhD prophylaxis from care after sensitisation

Fetal red cells can enter the maternal circulation during pregnancy or birth. An RhD-negative patient carrying an RhD-positive fetus can form immune anti-D. In a pregnancy with an antigen-positive fetus, maternal IgG can cross the placenta and cause fetal or neonatal haemolysis. Severe fetal anaemia can cause hydrops. Review positive antibody screens with transfusion medicine and the maternity team. Anti-D immunoglobulin prevents sensitisation in eligible patients. Established alloimmunisation requires specialist management.

Offer routine antenatal prophylaxis to eligible unsensitised RhD-negative patients according to the maternity protocol. When the service uses a validated fetal RHD result to guide prophylaxis, confirm fetal status with the local team. The Irish Rhophylac label provides a named example of 1,500 IU at 28–30 weeks. A potentially sensitising event requires a separate assessment even if routine prophylaxis has already been given. Examples include relevant abdominal trauma, late antepartum bleeding, amniocentesis or external cephalic version. Use the relevant early pregnancy guideline for miscarriage or ectopic pregnancy.

Offer postnatal anti-D to an unsensitised RhD-negative patient after birth of an RhD-positive infant as soon as possible and within 72 hours. Confirm the infant's RhD and follow the maternity and transfusion protocol for fetomaternal haemorrhage testing and any additional dose.

HPRA Rhophylac product information · Irish postnatal midwifery guideline, 2026 · Irish trauma anti-D guidance

Act on a potentially sensitising abdominal injury

SettingDecision under Irish Association for Emergency Medicine trauma guidance
Relevant abdominal injury at 12–20 weeksCheck group and antibody status. Offer eligible RhD-negative patients at least 250 IU anti-D within 72 hours. Fetomaternal haemorrhage testing is not routinely required in this gestational group.
Relevant abdominal injury after 20 weeksTake the maternal sample for fetomaternal haemorrhage testing before giving anti-D. For eligible RhD-negative patients the IAEM minimum is 500 IU within 72 hours. Use the actual local product and protocol, and adjust any further dose with the obstetric and transfusion teams.

The Kleihauer–Betke acid-elution test uses the relative acid resistance of fetal haemoglobin to estimate fetal cells in maternal blood. The laboratory may use flow cytometry to quantify the exposure. Interpret the report with the laboratory and check which units it uses before calculating additional anti-D. Seek advice if presentation is delayed. IAEM advises that there may still be benefit up to ten days after trauma.

Worked comparison. An unsensitised RhD-negative patient with relevant abdominal trauma and unknown fetal RhD at 17 weeks needs event-related anti-D, with no routine fetomaternal haemorrhage test under this guidance. With the same injury at 24 weeks, sample before treatment and use the result to assess the need for an additional dose. Assess the pregnancy and injuries in parallel.

Irish trauma anti-D guidance, 2024 · HPRA Rhophylac product information

Act on antenatal infection screening

Screening findingNext step
Positive HIV screenArrange confirmation and urgent specialist HIV and maternity review. Antiretroviral treatment and viral load guide delivery and neonatal prophylaxis. Discuss infant feeding with the specialist team. Formula avoids breast milk transmission. Effective treatment reduces the risk with breastfeeding, which requires an individual care and monitoring plan if chosen.
Positive hepatitis B surface antigenAssess maternal disease and HBV DNA with the specialist team. EASL recommends antiviral treatment to prevent transmission when HBV DNA is at least 200,000 IU/mL. Plan infant prophylaxis antenatally. Under NIAC guidance give monocomponent hepatitis B vaccine within 24 hours of birth and HBIG as soon as possible, ideally within 24 hours and no later than seven days. Give later doses as 6-in-1 vaccine at 2, 4 and 6 months, and arrange follow-up serology.
Positive syphilis serologyRefer promptly to a specialist sexual health service for confirmation, staging and coordinated maternity and neonatal care. Parenteral penicillin is first-line. The regimen depends on stage and clinical findings. Seek specialist advice if there is a penicillin allergy.
Rubella susceptibilityCheck documented vaccination as well as serology. NIAC accepts documented receipt of a rubella-containing vaccine as evidence of protection for rubella. If susceptible, advise prompt contact with maternity care after possible exposure or a compatible rash. Defer indicated MMR until after birth. Breastfeeding does not contraindicate it.

Early maternal rubella can cause congenital hearing loss, eye and cardiac defects. Live MMR is contraindicated during pregnancy. Discuss postpartum catch-up and review whether additional doses are needed for measles and mumps protection.

HSE antenatal infection screening · HSE HIV and pregnancy · EASL hepatitis B guidance · NIAC hepatitis B · HSE syphilis guidance · NIAC rubella

Distinguish gestational diabetes from pre-existing diabetes

Pregnancy increases insulin resistance. Gestational diabetes develops when pancreatic insulin secretion cannot meet the increased demand. Assess early for previously unrecognised diabetes, especially when hyperglycaemia is marked or detected at booking.

Plan pregnancy with established type 1 or type 2 diabetes

Refer for specialist pre-pregnancy care. Discuss continuing effective contraception during preparation and agree when to try to conceive. The HSE model aims for an HbA1c below 48 mmol/mol (6.5%) before conception when achievable without problematic hypoglycaemia. Review glucose monitoring, medicines and hypoglycaemia management. Arrange retinal screening and renal and blood-pressure assessment. Prescribe folic acid 5 mg daily before conception under the Irish diabetes pathway and confirm the planned duration with the maternity team. Review medicines that need changing before pregnancy. For example, plan a pregnancy-compatible alternative to an ACE inhibitor with the prescribing team and review statin and glucose-lowering therapy. Maintain essential insulin in type 1 diabetes and agree safe adjustment with the diabetes team.

If pregnancy is already confirmed, arrange early combined maternity and diabetes assessment without waiting for a routine gestational diabetes test. Review medicines and complications promptly, plan glucose and fetal monitoring and discuss sick-day action. In an unwell pregnant patient with diabetes, check blood ketones urgently, even if glucose is near normal. Vomiting or abdominal pain with ketosis and suspected acidosis requires emergency assessment for DKA with diabetes, critical care and obstetric input.

Glucose crosses the placenta. Sustained maternal hyperglycaemia can increase fetal insulin secretion and promote fetal growth. After birth the placental glucose supply stops while the infant's insulin response can persist. This increases the risk of neonatal hypoglycaemia. Large size for gestational age and macrosomia can affect labour and increase the risk of shoulder dystocia. Use the fetal growth trend, clinical setting and obstetric assessment when planning birth.

HSE diabetes in pregnancy model · IADPSG consensus criteria · HSE diabetes and pregnancy advice · NICE diabetes in pregnancy, preconception and ketosis recommendations

Interpret a gestational oral glucose tolerance test

The Irish national model recommends implementing universal screening, with either a one-step or a two-step strategy. It also describes risk-based practice in maternity units. Check the pathway in use. Risk factors include previous gestational diabetes, higher booking BMI, a prior large baby and a first-degree family history. The usual gestational screening window is 24–28 weeks. Assess for overt diabetes earlier under the maternity pathway.

In the one-step 75 g oral glucose tolerance test used at Cork University Hospital, one or more venous plasma values at or above the following thresholds meets the GDM criteria, unless the results meet criteria for overt diabetes.

SampleThreshold
Fasting5.1 mmol/L
1 hour after the glucose load10.0 mmol/L
2 hours after the glucose load8.5 mmol/L

Worked application. At 27 weeks, fasting 4.8, one-hour 10.3 and two-hour 7.6 mmol/L give one qualifying value. The one-hour value is 0.3 mmol/L above the diagnostic threshold. Use the diagnostic values for the laboratory test and the care team's capillary targets for subsequent monitoring.

Cork University Hospital laboratory handbook · HSE diabetes in pregnancy model

Loading diagram...
Gestational diabetes assessment and care

Manage glucose and plan follow-up

Arrange dietetic support, appropriate physical activity and home glucose monitoring. Use the maternity diabetes team's fasting and after-meal targets. For example, the HSE insulin titration guidance lists capillary targets below 5.3 mmol/L before meals and below 7.8 mmol/L one hour after meals, while avoiding excess hypoglycaemia. Review the pattern and fetal findings. If glucose remains above target or hyperglycaemia is marked, arrange specialist review for pharmacotherapy. Insulin or metformin can be appropriate depending on severity, glucose pattern, contraindications and preferences. People with pre-existing type 1 diabetes require insulin.

Use serial fetal growth assessment where indicated. Individualise timing and mode of birth according to glucose control, fetal growth and wellbeing, maternal complications and obstetric history. Suspected overgrowth prompts discussion of shoulder dystocia and birth options. Use the whole assessment to plan the mode of birth.

Review maternal medication and monitoring after delivery. Glucose-lowering drugs given solely for GDM can usually be stopped after birth with the agreed plan. Continue necessary treatment for pre-existing diabetes, with appropriate postpartum dose review. Support early feeding and monitor infants at risk of hypoglycaemia under the neonatal pathway. Glucose thresholds and the choice of feeding, dextrose gel or IV therapy depend on age, symptoms and protocol.

The Irish model recommends a postpartum oral glucose tolerance test at 6–12 weeks. After a normal result, review fasting glucose or HbA1c at one year and then at intervals of one to three years according to risk. Discuss diabetes prevention and planning for future pregnancy.

HSE diabetes in pregnancy model · Irish postnatal midwifery guideline, 2026 · HSE insulin titration guidance

Test Your Knowledge

At an Irish maternity unit using the IADPSG one-step criteria, a 28-year-old primigravida at 26 weeks gestation undergoes a 75g 2-hour Oral Glucose Tolerance Test (OGTT) due to a booking BMI of 33 kg/m2. Her results demonstrate a fasting plasma glucose of 5.4 mmol/L, a 1-hour glucose of 9.2 mmol/L, and a 2-hour glucose of 7.9 mmol/L. Ultrasound confirms a singleton fetus with an abdominal circumference on the 50th centile and normal liquor volume. What is the most appropriate initial management step?

A

Diagnose gestational diabetes mellitus and initiate lifestyle and dietary modifications with home blood glucose monitoring

B

Reassure the patient that the OGTT is normal because both the 1-hour and 2-hour postprandial values are below diagnostic thresholds

C

Immediately commence subcutaneous basal-bolus insulin therapy to prevent fetal macrosomia

D

Prescribe oral metformin 500 mg twice daily and repeat the OGTT in 4 weeks

Test Your Knowledge

A 31-year-old unsensitised RhD-negative woman at 29 weeks presents two hours after a road collision with blunt abdominal trauma. The fetal RhD type is unknown. The initial maternal and fetal assessments are reassuring, and she received routine anti-D at 28 weeks. While continuing the maternity assessment, what is the appropriate RhD prophylaxis?

A

Withhold anti-D because she already received routine antenatal prophylaxis.

B

Take a maternal sample for fetomaternal haemorrhage testing, then give prompt anti-D under the local protocol and use the result to determine any additional dose.

C

Give a fixed 250 IU dose without testing because she has no vaginal bleeding.

D

Arrange emergency caesarean birth to prevent sensitisation.

Test Your Knowledge

A 24-year-old attends booking at 11 weeks. Rubella IgG is below the laboratory threshold for immunity and no rubella-containing vaccine is documented. She has no rash or known exposure. Which advice is appropriate?

A

Administer MMR at the booking visit.

B

Reassure her that maternal rubella can no longer affect the fetus.

C

Advise her to contact the maternity service promptly after possible exposure or compatible rash, and offer indicated MMR after birth.

D

Prescribe acyclovir as antenatal rubella prophylaxis.

Test Your Knowledge

At 32 weeks, a patient develops intense itch on her palms and soles with no primary rash. There is no jaundice and fetal movements are unchanged. What is the most appropriate next step?

A

Reassure based on absence of jaundice and wait until after birth

B

Treat presumptive scabies without pregnancy assessment

C

Check only a urine dip and exclude cholestasis if it is normal

D

Contact the maternity team promptly and obtain serum bile acids and liver tests

Test Your Knowledge

A 29-year-old with type 1 diabetes and hypertension takes insulin and ramipril. She plans to try for pregnancy and has been using contraception. Her HbA1c is 65 mmol/mol and retinal screening is overdue. What is the most appropriate initial plan?

A

Stop insulin and ramipril immediately while using diet to control glucose

B

Advise proceeding now and arranging the routine gestational oral glucose tolerance test at 24–28 weeks as the first diabetes assessment

C

Refer for specialist pre-pregnancy care, maintain insulin, review ramipril and renal and retinal status, start high-dose folic acid and agree contraception while optimising glucose

D

Continue all medicines without review until the anomaly scan and use standard-dose folic acid

Test Your Knowledge

At an 11-week Irish maternity booking visit, a patient reports taking her prescribed opioid substitution treatment regularly. Her community prescriber confirms the current regimen. She is alert and has no signs of intoxication or withdrawal. What is the best initial plan?

A

Stop the treatment immediately to prevent neonatal withdrawal

B

Support continuity and coordinate early with maternity and the addiction prescriber, including a plan for the newborn

C

Switch her regimen immediately based on gestation alone

D

Delay discussion until the third trimester if she remains well

Sections you finish are checked off in the contents.